Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Involvement of extracellular signal-regulated kinase activation in human osteosarcoma cell resistance to the histone deacetylase inhibitor FK228 [(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-bis(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone].
Matsubara H, Watanabe M, Imai T, Yui Y, Mizushima Y, Hiraumi Y, Kamitsuji Y, Watanabe K, Nishijo K, Toguchida J, Nakahata T, Adachi S. Matsubara H, et al. Among authors: toguchida j. J Pharmacol Exp Ther. 2009 Mar;328(3):839-48. doi: 10.1124/jpet.108.147462. Epub 2008 Dec 10. J Pharmacol Exp Ther. 2009. PMID: 19073909
Mutation analysis of the RECQL4 gene in sporadic osteosarcomas.
Nishijo K, Nakayama T, Aoyama T, Okamoto T, Ishibe T, Yasura K, Shima Y, Shibata KR, Tsuboyama T, Nakamura T, Toguchida J. Nishijo K, et al. Among authors: toguchida j. Int J Cancer. 2004 Sep 1;111(3):367-72. doi: 10.1002/ijc.20269. Int J Cancer. 2004. PMID: 15221963
Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
Ishibe T, Nakayama T, Okamoto T, Aoyama T, Nishijo K, Shibata KR, Shima Y, Nagayama S, Katagiri T, Nakamura Y, Nakamura T, Toguchida J. Ishibe T, et al. Among authors: toguchida j. Clin Cancer Res. 2005 Apr 1;11(7):2702-12. doi: 10.1158/1078-0432.CCR-04-2057. Clin Cancer Res. 2005. PMID: 15814652
IGF2 preserves osteosarcoma cell survival by creating an autophagic state of dormancy that protects cells against chemotherapeutic stress.
Shimizu T, Sugihara E, Yamaguchi-Iwai S, Tamaki S, Koyama Y, Kamel W, Ueki A, Ishikawa T, Chiyoda T, Osuka S, Onishi N, Ikeda H, Kamei J, Matsuo K, Fukuchi Y, Nagai T, Toguchida J, Toyama Y, Muto A, Saya H. Shimizu T, et al. Among authors: toguchida j. Cancer Res. 2014 Nov 15;74(22):6531-41. doi: 10.1158/0008-5472.CAN-14-0914. Epub 2014 Oct 1. Cancer Res. 2014. PMID: 25273088
Expression of the chondromodulin-I gene in chondrosarcomas.
Aoyama T, Okamoto T, Nagayama S, Nishijo K, Ishibe T, Yasura K, Tsuboyama T, Nakayama T, Nakashima Y, Nakamura T, Toguchida J. Aoyama T, et al. Among authors: toguchida j. Cancer Lett. 2004 Feb 10;204(1):61-8. doi: 10.1016/j.canlet.2003.09.015. Cancer Lett. 2004. PMID: 14744535
Mutation analyses of the NFAT1 gene in chondrosarcomas and enchondromas.
Aoyama T, Nagayama S, Okamoto T, Hosaka T, Nakamata T, Nishijo K, Tsuboyama T, Nakayama T, Nakamura T, Toguchida J. Aoyama T, et al. Among authors: toguchida j. Cancer Lett. 2002 Dec 1;186(1):49-57. doi: 10.1016/s0304-3835(02)00106-4. Cancer Lett. 2002. PMID: 12183075
207 results